Page contentsPage contents Key facts Decision Key facts Active substance zosurabalpin Therapeutic area Infections and infestations Decision number EMA/PE/0000232777 PIP number EMA/PE/0000232777 Pharmaceutical form(s) Solution for infusion Condition(s) / indication(s) Treatment of infections due to organisms of the Acinetobacter baumannii-calcoaceticus complex Route(s) of administration Intravenous use Contact for public enquiries Roche Registration GmbHE-mail: global.paediatrics@roche.comTel. +41 6169 79411 Decision type P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) Decision date 16/05/2025 Compliance check done No Decision EMA/PE/0000232777 : EMA decision of 16 May 2025 on the agreement of a paediatric investigation plan and on the granting of a deferral for zosurabalpinAdopted Reference Number: EMADOC-1700519818-2113581 English (EN) (264.77 KB - PDF)First published: 14/07/2026 View Share this page